Purpose of Review: The recent literature on spasmodic dysphonia is reviewed with regard to pathogenesis, differential diagnosis, treatment options, audits, and current methods of which impinges on all aspects of their lives. Spasmodic dysphonia is now classified as a "rare" disease in the USA. This designation will assist in international standards of diagnosis, assessment, treatment, and management.